Vanguard Health Care's impressive team and time-tested approach make it an attractive offering.
Vanguard Health Care Inv VGHCX
- NAV / 1-Day Return 201.72 / +0.28 %
- Total Assets 47.4 Bil
-
Adj. Expense Ratio
0.340%
- Expense Ratio 0.340%
- Distribution Fee Level Low
- Share Class Type No Load
- Category Health
- Investment Style Large Growth
- Min. Initial Investment 3,000
- Status Open
- TTM Yield 0.79%
- Turnover 16%
USD | NAV as of Apr 19, 2024 | 1-Day Return as of Apr 19, 2024, 10:18 PM GMT+0
Morningstar’s Analysis VGHCX
Will VGHCX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 43.2
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 7.32 | 3.4 Bil | Healthcare |
UnitedHealth Group Inc | 6.79 | 3.2 Bil | Healthcare |
AstraZeneca PLC | 5.60 | 2.6 Bil | Healthcare |
Merck & Co Inc | 4.81 | 2.2 Bil | Healthcare |
Novartis AG Registered Shares | 4.67 | 2.2 Bil | Healthcare |
Pfizer Inc | 3.70 | 1.7 Bil | Healthcare |
Abbott Laboratories | 2.72 | 1.3 Bil | Healthcare |
Danaher Corp | 2.55 | 1.2 Bil | Healthcare |
Daiichi Sankyo Co Ltd | 2.55 | 1.2 Bil | Healthcare |
Biogen Inc | 2.54 | 1.2 Bil | Healthcare |